Thyroid Transcription Factor 1 (TTF-1), also known as NK2 homeobox 1 (NKX2-1), is a lineage-specific homeodomain transcription factor that plays a fundamental role in the embryonic development of the lung, thyroid, and ventral forebrain, as well as in pulmonary epithelial differentiation and maintenance of respiratory epithelial cell identity. In normal adult lung tissue, TTF-1 is predominantly expressed in type II pneumocytes and bronchiolar club cells, where it regulates genes involved in surfactant production and epithelial homeostasis. Persistent expression in pulmonary epithelial-derived neoplasms makes TTF-1 a valuable biomarker for diagnostic immunohistochemistry in thoracic pathology.

Diagnostic Utility of Anti-TTF-1 (NKX2-1) in Pulmonary Pathology

Anti-TTF-1 antibodies are among the most widely used immunohistochemical markers for the classification of primary lung tumors. Nuclear TTF-1 expression is detected in approximately 70–85% of pulmonary adenocarcinomas and in the vast majority of small cell lung carcinomas, while most pulmonary squamous cell carcinomas are negative and many extrapulmonary carcinomas lack expression. Notable exceptions include thyroid carcinomas and selected neuroendocrine neoplasms.

Consequently, TTF-1 is routinely incorporated into diagnostic IHC panels to:

• Support the identification of primary lung adenocarcinoma.
• Distinguish lung adenocarcinoma from metastatic non-pulmonary carcinomas.
• Aid in the diagnosis of small cell lung carcinoma.
• Assist in the subclassification of non-small cell lung carcinoma (NSCLC).
• Contribute to the evaluation of metastatic tumors of unknown primary origin.

Clone-dependent differences in sensitivity and specificity have been reported, with 8G7G3/1 generally exhibiting higher specificity, whereas SPT24 may demonstrate greater sensitivity, particularly in poorly differentiated pulmonary adenocarcinomas.

Key Features of TTF-1 (NKX2-1) CE/IVD Antibodies

Common characteristics of CE/IVD-validated Anti-TTF-1 antibodies include:

• Detection of nuclear TTF-1/NKX2-1 expression in formalin-fixed, paraffin-embedded (FFPE) tissues.
• Optimized for diagnostic immunohistochemistry (IHC) workflows.
• Availability as ready-to-use (RTU) and concentrated formats.
• High sensitivity for lung adenocarcinoma and small cell lung carcinoma.
• Compatibility with automated staining platforms and standard antigen retrieval protocols.
• Intended for use in thoracic oncology, pulmonary pathology, and cancer diagnostic laboratories.